Dr. Studts enjoyed a productive and rewarding research, mentoring and service year in 2016. With regard to his research efforts, Dr. Studts continues to serve as the principal investigator of the Kentucky LEADS Collaborative, a multi-level, interdisciplinary project dedicated to developing and evaluating novel provider education, survivorship care, and prevention and early detection interventions to reduce reducing the burden of lung cancer in Kentucky. Dr. Studts also initiated work on a grant from the Kentucky Lung Cancer Research Board to continue his research in implementation of lung cancer screening to go along with his NCI-funded research developing a lung cancer screening decision support tool in collaboration with Dr. Margaret Byrne at the University of Miami. Dr. Studts continued his work with Health Decision Technologies, studying novel point-of-care software package to promote implementation of evidence-based tobacco cessation strategies in dental care settings (NIDCR SBIR) and completing a project in obstetrics (NIDA STTR). In collaboration with Drs. Joe Valentino and Christina Studts, Dr. Studts co-leads a clinical trial examining the impact of evidence-based tobacco cessation interventions among individuals recently diagnosed with lung or head/neck cancer, funded by a grant from the Kentucky Lung Cancer Research Program and supported by the Kentucky Clinical Trials Network. Also supported by the Kentucky Lung Cancer Research Program, Dr. Studts is working with Dr. Kate Eddens on her study exploring social network communication regarding lung cancer screening. In collaboration with colleagues at West Virginia University, Dr. Studts has initiated a new study funded by the NCI to study a novel intervention to communicate risk of breast cancer recurrence following treatment for breast cancer. Dr. Studts has continued to work as a co-investigator on an NIEHS funded grant with Dr. Ellen Hahn to conduct a randomized trial of a lung cancer prevention trial involving radon and nicotine testing as well as a NIDA funded grant to Dr. Hannah Knudsen exploring implementation and provider decision making regarding buprenorphine. Dr. Studts published 3 peer-reviewed academic papers in 2016, delivered 18 invited talks and 10 conference presentations. In the teaching/mentoring domain, Dr. Studts continues to serve as the primary mentor for Dr. Jessica Burris’ NCI career development grant and co-mentor for Dr. Kate Eddens BIRCWH career development award. Dr. Studts also mentored 2 medical students, 4 graduate students, and served on 3 graduate committees. With regard to academic and scientific service, Dr. Studts chaired the Quality of Life study section for the Canadian Cancer Society Research Institute, and served as a panel member for the Kentucky Lung Cancer Research Program, the Iowa Cancer Coalition Grant Review Panel, the Markey Cancer Center Pilot Program, and the Markey ACS-IRG, and the SBM Cancer SIG-ACS Seed Money Grant Review. He reviewed 15 manuscripts for scientific journals and abstracts for 5 academic conferences and served on the editorial board for the journals Medical Decision Making, Journal of Behavioral Medicine, and Medical Decision Making: Policy & Practice. Dr. Studts continued to serve as the Assistant Director of Cancer Prevention and Control and the Director of the Behavioral and Community-Based Research Shared Resource Facility for the Markey Cancer Center. Dr. Studts also serves as a member of the Markey Cancer Center Membership Committee and the Protocol Review and Monitoring Committee. Within the Department of Behavioral Science, Dr. Studts served as a member of the Admissions Committee and the Curriculum Committee. On the state level, Dr. Studts co-leads the Kentucky Lung Cancer Prevention and Early Detection Network of the Kentucky Cancer Consortium and continues to serve on its Survivorship Working Group, the Affordable Care Act and the Radon Action subcommittees. Finally, Dr. Studts serves as a member of the Steering Committee for the UK Center for Health Services Research and a member of the UK Senate Advisory Committee on Faculty Code. In 2016, Dr. Studts accepted an invitation to serve on the Medical and Professional Advisory Board of the Lung Cancer Alliance. In perhaps the most rewarding experience of his career, Dr. Studts was invited to serve on the Workgroup Planning Committee for the Institute of Medicine National Cancer Policy Forum on Implementation of Lung Cancer Screening and was invited to serve as a presenter and moderator for the meeting held this past summer.
Principal Investigator,“Attitudes and Beliefs regarding Nicotine Vaccines as Treatment and Prophylaxis for Nicotine Dependence,” Kentucky Lung Cancer Research Program (2006-2008).
Co-Investigator, “Telehealth Symptom Management in Head and Neck Cancer,” National Cancer Institute (2005-2007).
Principal Investigator, “Adjuvant Treatment Decision Making for Lung Cancer,” National Cancer Institute (2005-2008).
Principal Investigator, “Behavioral, Cognitive, and Affective Responses to Lung Cancer Screening,” Kentucky Lung Cancer Research Program (2003-2008).
Principal Investigator, “Behavioral Oncology Clinic – Breast Program,” Susan G. Komen Breast Cancer Foundation – Louisville Affiliate (2003-2007).
Co-Investigator, “Cancer as a Chronic Disease,” Centers for Disease Control & Prevention (2005-2006)
Studts, J. L., Matera, E. L., Worth, C. T., Ghate, S. R., Miller, B. F., Thomas, S. D., & Sorrell, C. L. (In press). Tobacco cessation treatment knowledge, attitudes and practices of Kentucky physicians. Journal of the Kentucky Medical Association.
Studts, J. L., Ghate, S. R., Marmorato, J. L., Studts, C. R., Barnes, C. N., LaJoie, A. S., Andrykowski, M. A., & LaRocca, R. V. (2006). Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiology, Biomarkers and Prevention, 15, 1825-1828.
Chagpar, A. B., Studts, J. L., Scoggins, C. R., Martin, R. C. G., Carlson, D. J., Laidley, A. L., El-Eid, S. E., McGlothin, T. E., Noyes, R. D., & McMasters, K. M. (2006). Factors associated with breast cancer surgical options. Cancer, 106, 1462-1466.
Martin, R. C. G., McGuffin, S. A., Roetzer, L. M., Abell, T. D., & Studts, J. L. (2006). Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer. Annals of Surgical Oncology, 13, 86-95.
Studts, J. L., Abell, T. D., Roetzer, L. M., Albers, A. N., McMasters, K. M., & Chao, C. (2005). Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer. Psycho-oncology, 14, 647-660.
Chao, C., Studts, J. L., Abell, T., Hadley, T., Roetzer, L., Dineen, S., Lorenz, D., YoussefAgha, A., McMasters, K. M. (2003). Adjuvant chemotherapy for breast cancer: How presentation of recurrence risk influences decision-making. Journal of Clinical Oncology, 21, 4299-4305.